Product

Plavix


AIM: New study refutes FDA's contraindication for Plavix and PPIs

Clinical Studies | Wednesday, March 17 2010
 

ACC: Plavix+aspirin, for those who can’t take warfarin, doesn't increase costs

Top Stories | Sunday, March 14 2010
Written by Justine Cadet
 

Circulation: CAD patients RESPOND to clopidogrel after treatment with ticagrelor

Clinical Studies | Wednesday, March 10 2010
 

Circulation: Clopidogrel helps halt stroke recurrence after carotid stenting

Clinical Studies | Thursday, February 18 2010
 

Lancet: Ticagrelor could “redefine” care of ACS patients due to mortality reduction

Top Stories | Thursday, January 14 2010
 

AstraZeneca submits ticagrelor for FDA approval

Regulatory News | Friday, November 20 2009
 

AHA: Cangrelor fails to become a CHAMPION in two randomized, controlled trials

Conference News | Monday, November 16 2009
 

Report: Stronger U.S. pharma sales will lead 2010 global market to $825M

Financial News | Thursday, October 08 2009
 

TCT: COGENT dispels questions about combining Plavix, proton pump inhibitors

Conference News | Thursday, September 24 2009
 

TCT: Dual-antiplatelet therapy—is two years superior to one for late thrombosis?

Conference News | Tuesday, September 22 2009
 

ACC Feature: SORTing OUT Endeavor’s inferiority to Cypher

Top Stories | Monday, March 15 2010
Written by Justine Cadet
 

FDA slaps black box warning on Plavix for poor metabolizers

Top Stories | Friday, March 12 2010
 

CVD pharma companies face a tough decade

Top Stories | Wednesday, March 03 2010
 

AntiPlatelet Therapy: Widening Options & Opinions

Cover Story | Thursday, January 28 2010
 

Lancet: Antithrombotic drug therapy needs to be more carefully tailored to MI patients

Clinical Studies | Monday, December 14 2009
 

Did FDA ignore COGENT to slap warning on clopidogrel/PPI interaction?

Top Stories | Thursday, November 19 2009
 

AHA: Ticagrelor bests Plavix in STEMI patients, includes mortality reduction

Conference News | Sunday, November 15 2009
 

Dual-antiplatelet therapy trial begins enrollment

Industry News | Tuesday, October 06 2009
 

TCT: Prasugrel costs hospitals less than clopidogrel, due to less repeat PCI

Conference News | Thursday, September 24 2009
 

Gregg Stone previews major trials, sessions at TCT

Top Stories | Thursday, September 17 2009
 


Web Exclusives

Commentary: Atrial fibrillation strikes an electrophysiologist

 Middle age introduces itself in many ways; one is atrial fibrillation (AF). My onset of AF seems to have coincided with a mountain bike accident in the woods of North Carolina that resulted in some cracked ribs.

AHRQ: Health IT could be disruptive while reducing rehospitalization rates, costs

 The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).

New patient monitoring model draws scrutiny

 A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.

Commentary: Overcoming challenges with drug-eluting stents

 There are cases presented to all physicians when we have to balance benefits of a particular treatment with concerns around safety for certain patients. In interventional cardiology, we see this dilemma with drug-eluting stents (DES). While this technology provides effective therapy for many patients with ischemia-inducing coronary lesions, there are certain patient groups that encounter problems for different reasons.